stockrow
Saturday 7 November 2026
Export BCTX’s income statement to Excel — free account
BRIACELL THERAP
BCTX Healthcare Biotechnology
- EPS
- +110.2%
- Free cash flow
- +26.7%
Quarter to July 2026, against a year earlier
4.00
0.73
+22.32%
Follow BCTX
Alert me
| Jul '17 | Jul '18 | Jul '19 | Jul '20 | Jul '21 | Jul '22 | Jul '23 | Jul '24 | Jul '25 | Jul '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
1.84 | 1.40 | 0.15 | 0.07 | 103.80 | 45.00 | 14.96 | 0.49 | 5.01 | 2.76 |
Net Debt/EBITDA |
0.63 | 0.17 | (0.03) | 0.01 | 8.23 | 2.69 | 0.91 | 0.03 | 0.66 | 0.57 |
Debt/Assets |
0.00% | 49.05% | 72.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 1.19 | (0.47) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.59 | 0.92 | 0.88 | 0.31 | 0.56 | 0.47 | 1.17 | 5.04 | 1.07 | 0.82 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (5.44) | 0.00 | (1.06) |
Interest Coverage |
— | (244.28) | (198.33) | (133.54) | (88.75) | (15,288.90) | (25.69) | — | — | — |
| (329.47%) | (509.54%) | (2,667.58%) | 189.99% | (114.78%) | (141.26%) | (619.76%) | 148.30% | (359.23%) | (212.23%) | |
| (205.57%) | (219.39%) | (317.98%) | (860.95%) | (47.18%) | (53.35%) | (58.22%) | (29.01%) | (191.21%) | (154.34%) | |
ROIC |
0.00% | (754.89%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(345.31%) | (772.93%) | 488.44% | 108.70% | (24.14%) | (64.82%) | (80.73%) | 140.14% | (161.97%) | (242.68%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.12 | 0.62 | 0.50 | 0.00 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(635.84) | (1,365.49) | (995.93) | (263.73) | (257.48) | (120.86) | (227.88) | (224.09) | (66.58) | (5.74) |
Cash per Share |
670.55 | 627.71 | 37.70 | 4.42 | 1,902.61 | 397.31 | 203.95 | 7.86 | 42.23 | 4.10 |
Shareholders Equity per Share |
311.25 | 339.08 | (165.41) | (749.46) | 919.33 | 99.99 | (36.25) | (24.47) | 40.97 | 3.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
311.25 | 339.08 | (165.41) | (749.46) | 919.33 | 99.99 | (36.25) | (24.47) | 40.97 | 3.11 |
Free Cash Flow |
(1.44) | (3.89) | (3.85) | (1.27) | (7.75) | (12.48) | (23.74) | (24.58) | (28.17) | (28.78) |
Working Capital |
0.70 | 0.55 | (0.90) | (3.70) | 57.24 | 41.41 | 25.15 | (3.81) | 15.95 | 14.06 |
Capital Expenditures |
0.00 | — | — | — | — | — | — | (0.46) | — | (0.13) |
Net Current Asset Value |
0.70 | 0.55 | (0.90) | (3.86) | 27.43 | 10.10 | (3.99) | (4.90) | 15.61 | 14.02 |
| Other line items | ||||||||||
Quick Ratio |
1.83 | 1.32 | 0.14 | 0.01 | 102.88 | 43.64 | 14.96 | 0.49 | 5.01 | 2.76 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.36 | 0.37 |
Cash ROIC |
(64.76%) | (99.75%) | 1,981.82% | 35.40% | (9.12%) | (24.30%) | (135.89%) | 1,348.63% | (80.03%) | (79.72%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(635.84) | (1,365.49) | (995.93) | (263.73) | (257.48) | (120.86) | (227.88) | (219.93) | (66.58) | (5.72) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (4.16) | 0.00 | (0.03) |
Average Receivables |
0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 2.86 | 4.24 | 2.43 | 1.78 |
Average Payables |
0.21 | 0.29 | 0.49 | 2.23 | 1.96 | 0.34 | 0.79 | 4.15 | 5.23 | 5.14 |
Average Assets |
1.18 | 1.94 | 1.38 | 0.47 | 29.28 | 50.31 | 34.87 | 16.52 | 13.76 | 22.61 |
Average Common Equity |
0.74 | 0.83 | 0.16 | (2.12) | 12.04 | 19.00 | 3.28 | (3.23) | 7.32 | 16.45 |
Capex to Sales |
0.00 | — | — | — | — | — | — | 0.00 | — | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026